Position in HROW
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$257,920
+$43,787 QoQ
Shares Held
6,073
0.0% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#141
of 224 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HROW Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026SJS Investment Consulting Inc. holds $550,595 across 35 Drug Manufacturers - Specialty & Generic names. HROW ranks #1 (46.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HROW |
Harrow, Inc.
This page
|
6,073 | $257,920 | |
| 2 | ZTS |
Zoetis Inc.
|
770 | $55,331 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
255 | $42,977 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,285 | $36,627 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
54 | $29,258 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
1,180 | $29,039 | |
| 7 | VTRS |
Viatris Inc
|
895 | $14,212 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
348 | $12,064 |
All Filings in HROW
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $257,920 | 6,073 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $214,133 | 6,073 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $297,577 | 6,073 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $292,597 | 6,073 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $185,469 | 6,073 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $81,741 | 3,073 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $103,099 | 3,073 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $138,162 | 3,073 | Shares | Sole | 2024-10-16 | |
| No filing history on record for this holder in this stock. | ||||||